99 related articles for article (PubMed ID: 10095425)
41. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
42. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
Lenos K; Grawenda AM; Lodder K; Kuijjer ML; Teunisse AF; Repapi E; Grochola LF; Bartel F; Hogendoorn PC; Wuerl P; Taubert H; Cleton-Jansen AM; Bond GL; Jochemsen AG
Cancer Res; 2012 Aug; 72(16):4074-84. PubMed ID: 22700878
[TBL] [Abstract][Full Text] [Related]
43. Nuclear p63 expression in osteoblastic tumors.
Kallen ME; Sanders ME; Gonzalez AL; Black JO; Keedy VL; Hande KR; Homlar KC; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Cates JM
Tumour Biol; 2012 Oct; 33(5):1639-44. PubMed ID: 22623071
[TBL] [Abstract][Full Text] [Related]
44. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
[TBL] [Abstract][Full Text] [Related]
45. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
46. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
47. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
Waber PG; Chen J; Nisen PD
Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417
[TBL] [Abstract][Full Text] [Related]
48. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
[TBL] [Abstract][Full Text] [Related]
49. Large cell, epithelioid, telangiectatic osteoblastoma: a unique pseudosarcomatous variant of osteoblastoma.
Angervall L; Persson S; Stenman G; Kindblom LG
Hum Pathol; 1999 Oct; 30(10):1254-9. PubMed ID: 10534176
[TBL] [Abstract][Full Text] [Related]
50. Histones and their practical application in bone tumors: Do I always need them?
Reith JD
Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
[TBL] [Abstract][Full Text] [Related]
51. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma.
Saba KH; Cornmark L; Hofvander J; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Foijer F; Staaf J; Brosjö O; Sumathi VP; Lam SW; Szuhai K; Bovée JV; Kovac M; Baumhoer D; Styring E; Nord KH
J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935
[TBL] [Abstract][Full Text] [Related]
52. Osteoblastoma of the thumb with a novel PRSS44::ALK fusion and literature review of osteoblastoma of hands and feet bones.
Brandea AI; Afkhami M; Klein MJ; Bell D
Genes Chromosomes Cancer; 2024 May; 63(5):e23241. PubMed ID: 38738966
[TBL] [Abstract][Full Text] [Related]
53. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract][Full Text] [Related]
54. Recurrent H3.3 alterations in childhood tumors.
Lindroth AM; Plass C
Nat Genet; 2013 Dec; 45(12):1413-4. PubMed ID: 24270444
[TBL] [Abstract][Full Text] [Related]
55.
Panagopoulos I; Gorunova L; Lobmaier I; Andersen K; Kostolomov I; Lund-Iversen M; Bjerkehagen B; Heim S
Cancer Genomics Proteomics; 2020; 17(2):161-168. PubMed ID: 32108038
[TBL] [Abstract][Full Text] [Related]
56. Late-onset spondylarthropathy mimicking multiple osteoblastic metastases.
Pottecher P; Bry J; Krause D; Ornetti P
Joint Bone Spine; 2012 Oct; 79(5):517. PubMed ID: 22771134
[No Abstract] [Full Text] [Related]
57. Osteogenic Tumors.
Domansk HA; Walther CS
Monogr Clin Cytol; 2017; 22():139-146. PubMed ID: 28750390
[No Abstract] [Full Text] [Related]
58. Molecular and Translational Research on Bone Tumors.
Rossi M; Del Fattore A
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768270
[TBL] [Abstract][Full Text] [Related]
59. Nanosensors for cancer detection.
Huber F; Lang HP; Zhang J; Rimoldi D; Gerber C
Swiss Med Wkly; 2015; 145():w14092. PubMed ID: 25664868
[TBL] [Abstract][Full Text] [Related]
60. Breathlessness with pulmonary metastases: a multimodal approach.
Brant JM
J Adv Pract Oncol; 2013 Nov; 4(6):415-22. PubMed ID: 25032021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
